Typically, discourses concerning innovative health financing mechanisms for vaccines revolve around new mechanisms that have successfully funded vaccine research, manufacturing and purchase. Meanwhile, a critical yet often overlooked aspect of innovative vaccine financing mechanisms is the challenge of striking the right balance between managing access to the finance and beneficiary autonomy. Africa’s continental response to COVID-19, which was characterized by the use of innovative vaccine procurement mechanisms, demonstrates the importance of autonomous application of external aid in promoting ownership and a more timely response to public health emergencies.